Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

946 ARTÍCULOS , VIENDO DEL 151 AL 165

Protective effect of flavonoids on oxidative stress injury in Alzheimer's disease

Wang K, Chen X.

Nat Prod Res. 2025 Mar;39(5):1272-1299. doi: 10.1080/14786419.2024.2345760. Epub 2024 Jun 23.

Immunotherapies: A Treasure Trove of Alzheimer's Disease

Kolay A, Singh N, Gupta P, Shaikh AM, Goel R, Nagpal D, Chitme H.

Curr Pharm Biotechnol. 2025;26(12):1936-1949. doi: 10.2174/0113892010308600240709052539.

Melatonin: A potential nighttime guardian against Alzheimer's

Zhang Z, Xue P, Bendlin BB, Zetterberg H, De Felice F, Tan X, Benedict C.

Mol Psychiatry. 2025 Jan;30(1):237-250. doi: 10.1038/s41380-024-02691-6. Epub 2024 Aug 11.

Apolipoprotein E in Alzheimer's Disease: Focus on Synaptic Function and Therapeutic Strategy

Qu L, Xu S, Lan Z, Fang S, Xu Y, Zhu X.

Mol Neurobiol. 2025 Mar;62(3):3040-3052. doi: 10.1007/s12035-024-04449-1. Epub 2024 Aug 31.

Exploring the Mechanisms and Therapeutic Approaches of Mitochondrial Dysfunction in Alzheimer's Disease: An Educational Literature Review

Moawad MHED, Serag I, Alkhawaldeh IM, Abbas A, Sharaf A, Alsalah S, Sadeq MA, Shalaby MMM, Hefnawy MT, Abouzid M, Meshref M.

Mol Neurobiol. 2025 Jun;62(6):6785-6810. doi: 10.1007/s12035-024-04468-y. Epub 2024 Sep 10.

Stem Cells as a Novel Source for Regenerative Medicinal Applications in Alzheimer's Disease: An Update

Pandey K, Srivastava P, Pandey SK, Johari S, Bhatnagar P, Sonane M, Mishra A.

Curr Mol Med. 2025;25(2):146-166. doi: 10.2174/0115665240334785240913071442.

Emerging advances in nano-biomaterial assisted amyloid beta chimeric antigen receptor macrophages (CAR-M) therapy: reducing plaque burden in Alzheimer's disease

Kushwaha N, Panjwani D, Patel S, Ahlawat P, Yadav MR, Patel AS.

J Drug Target. 2025 Feb;33(2):185-205. doi: 10.1080/1061186X.2024.2417012. Epub 2024 Oct 21.

Cutting-edge Strategies for Overcoming Therapeutic Barriers in Alzheimer's Disease

Inamdar A, Gurupadayya B, Halagali P, Nandakumar S, Pathak R, Singh H, Sharma H.

Curr Pharm Des. 2025;31(8):598-618. doi: 10.2174/0113816128344571241018154506.

Disease-modifying therapies for Alzheimer's disease: Clinical trial progress and opportunity

Zhang Y, Chen J, Li Y, Jiao B, Luo S.

Ageing Res Rev. 2025 Jan;103:102595. doi: 10.1016/j.arr.2024.102595. Epub 2024 Nov 22.

Recent Studies on Heterocyclic Cholinesterase Inhibitors Against Alzheimer's Disease

Tok F.

Chem Biodivers. 2025 Apr;22(4):e202402837. doi: 10.1002/cbdv.202402837. Epub 2024 Dec 3.

The immunomodulatory effects of psychedelics in Alzheimer's disease-related dementia

Mohammad Hosseini A, Khaleghzadeh-Ahangar H, Rahimi A.

Neuroscience. 2025 Jan 9;564:271-280. doi: 10.1016/j.neuroscience.2024.11.062. Epub 2024 Nov 26.

TREM2 bridges microglia and extracellular microenvironment: Mechanistic landscape and therapeutical prospects on Alzheimer's disease

Zhao Y, Guo Q, Tian J, Liu W, Wang X.

Ageing Res Rev. 2025 Jan;103:102596. doi: 10.1016/j.arr.2024.102596. Epub 2024 Nov 27.

Shedding light on microglial dysregulation in Alzheimer's disease: exploring molecular mechanisms and therapeutic avenues

Bhardwaj V, Kumari S, Dhapola R, Sharma P, Beura SK, Singh SK, Vellingiri B, HariKrishnaReddy D.

Inflammopharmacology. 2025 Feb;33(2):679-702. doi: 10.1007/s10787-024-01598-6. Epub 2024 Nov 28.

Review on pathogenesis and treatment of Alzheimer's disease

Cai J, Liu Y, Fan H.

Dev Dyn. 2025 Apr;254(4):296-309. doi: 10.1002/dvdy.762. Epub 2024 Dec 9.

Exploring neurosurgical interventions in Alzheimer's disease: current perspectives and future directions

Kathiresan N, Selvaraj C, Subbaraj GK, Langeswaran K.

Neurol Sci. 2025 Apr;46(4):1925-1927. doi: 10.1007/s10072-024-07925-7. Epub 2024 Dec 10.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias